Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NYSE:OPK)

16.37
Delayed Data
As of Jul 31
 -0.01 / -0.06%
Today’s Change
8.02
Today|||52-Week Range
19.20
+63.86%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$7.6B

Company Description

OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company. The company is engaged in discovering, developing, commercializing and expertise its novel and proprietary technologies with a focus to provide unmet medical needs through a range of develops solutions to diagnose, treat and prevent various conditions, including molecular diagnostics, point-of-care tests and proprietary pharmaceuticals and vaccines. It operates its business through two segments: Pharmaceutical and Diagnostics. The Pharmaceutical segment consists of pharmaceutical research and development, which is focused on the research and development of pharmaceutical products and vaccines. The Diagnostics segment consists of pathology operations and point-of-care and molecular diagnostics operations. OPKO Health was founded in October 1991 and is headquartered in Miami, FL.

Contact Information

OPKO Health, Inc.
4400 Biscayne Boulevard
Miami Florida 33137
P:(305) 575-4100
Investor Relations:

Employees

Shareholders

Mutual fund holders8.04%
Individual stakeholders48.02%
Other institutional10.07%

Top Executives

Phillip FrostChairman & Chief Executive Officer
Adam E. LogalChief Financial Officer, Treasurer, CAO & SVP
Jane H. HsiaoVice Chairman & Chief Technology Officer
Stephen A. StrugnellSenior Director-Scientific Affairs
Steven D. RubinDirector & Executive Vice President-Administration